Taiwan AI Labs aligns with international standards for trustworthy and responsible AI. We have partnered with the U.S. Centers for Disease Control and Prevention (CDC) and received recognition from Henry Rodriguez, Assistant Director for Strategic Health and Cancer Science, in the Executive Office of the President at the White House, who is also the Founding Director of the Office of Cancer Clinical Proteomics Research at the National Cancer Institute, NIH, for our collaborative work in areas like brain tumor diagnosis and multi-gene risk models.

Furthermore, we have signed Memoranda of Understanding (MOUs) with international medical institutions, including South Korea's Samsung Medical Center and institutions in Pakistan, to foster clinical and research partnerships. We are also in discussions with medical centers, equipment manufacturers, and instrument manufacturers in Europe and the United States for potential business collaborations.

National Pharmaceutical Science and Technology Development Award jointly presented by the Ministry of Health and Welfare's Food and Drug Administration and the Ministry of Economic Affairs' Industrial Development Bureau. DeepMets® has been implemented in hospitals such as Taipei Veterans General Hospital, Taichung Veterans General Hospital, Hualien Tzu Chi Hospital, Shuang Ho Hospital, Yuan General Hospital. It has also acquired registration for AI medical devices in Vietnam, paving the way for entry into the healthcare market of Southeast Asia with a population of over five billion, marking a significant milestone in overseas markets.